🇺🇸 Thiuram in United States
11 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 30 March 2025 – 30 March 2026
- Total reports: 11
Most-reported reactions
- Dermatitis Contact — 3 reports (27.27%)
- Therapeutic Product Cross-Reactivity — 3 reports (27.27%)
- Abdominal Pain — 1 report (9.09%)
- Drug Reaction With Eosinophilia And Systemic Symptoms — 1 report (9.09%)
- Eosinophilia — 1 report (9.09%)
- Hepatocellular Injury — 1 report (9.09%)
- Renal Failure — 1 report (9.09%)
Other Other approved in United States
Frequently asked questions
Is Thiuram approved in United States?
Thiuram does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Thiuram in United States?
Marketing authorisation holder not available in our data.